Vector-borne illnesses comprise a significant portion of human maladies, representing 17%
of global infections. Transmission of vector-borne pathogens to mammals primarily occurs …

Biofluid metabolomics is a popular tool for biomarker discovery to decipher disease-,
genetics-, and exposure-related metabolic alterations and is an essential component for …

The emergence of Zika virus (ZIKV) as a global health threat has highlighted the unmet need
for ZIKV-specific vaccines and antiviral treatments. ZIKV infects dendritic cells (DC), which …

The magnitude of infectious diseases in the twenty-first century created an urgent need for
point-of-care diagnostics. Critical shortages in reagents and testing kits have had a large …

Migration is a known phenomenon defined as the partitioning of chemical compounds from
the packaging into food, and depends on several factors. Migration assays are generally …

Viral emergence is an unpredictable but obvious event, particularly in the era of climate
change and globalization. Efficient management of viral outbreaks depends on pre-existing …

COVID-19 is an emergent, worldwide public health concern. Joint efforts have been made
by scientific communities of various fields to better understand the mechanisms of action of …

The global burden of arboviral diseases and the limited success in controlling them calls for
innovative methods to understand arbovirus infections. Metabolomics has been applied to …

Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the Flavivirus genus of the
Flaviviridae family. Since the large outbreaks in French Polynesia in 2013–2014 and in …

Current and reoccurring viral epidemic outbreaks such as those caused by the Zika virus
illustrate the need for rapid development of antivirals. Such development would be facilitated …